BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reay WR, Cairns MJ. Advancing the use of genome-wide association studies for drug repurposing. Nat Rev Genet 2021;22:658-71. [PMID: 34302145 DOI: 10.1038/s41576-021-00387-z] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 21.5] [Reference Citation Analysis]
Number Citing Articles
1 Farrell SF, Kho PF, Lundberg M, Campos AI, Rentería ME, de Zoete RMJ, Sterling M, Ngo TT, Cuéllar-Partida G. A Shared Genetic Signature for Common Chronic Pain Conditions and its Impact on Biopsychosocial Traits. J Pain 2023;24:369-86. [PMID: 36252619 DOI: 10.1016/j.jpain.2022.10.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Silveira PP, Meaney MJ. Examining the biological mechanisms of human mental disorders resulting from gene-environment interdependence using novel functional genomic approaches. Neurobiol Dis 2023;178:106008. [PMID: 36690304 DOI: 10.1016/j.nbd.2023.106008] [Reference Citation Analysis]
3 Adams DM, Reay WR, Cairns MJ. Multiomic prioritisation of risk genes for anorexia nervosa. Psychol Med 2023;:1-9. [PMID: 36803885 DOI: 10.1017/S0033291723000235] [Reference Citation Analysis]
4 Ortiz-Fernández L, Carmona EG, Kerick M, Lyons P, Carmona FD, López Mejías R, Khor CC, Grayson PC, Tombetti E, Jiang L, Direskeneli H, Saruhan-Direskeneli G, Callejas-Rubio JL, Vaglio A, Salvarani C, Hernández-Rodríguez J, Cid MC, Morgan AW, Merkel PA, Burgner D, Smith KG, Gonzalez-Gay MA, Sawalha AH, Martin J, Marquez A. Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing. Ann Rheum Dis 2023:ard-2022-223697. [PMID: 36797040 DOI: 10.1136/ard-2022-223697] [Reference Citation Analysis]
5 Li J, Meng L, Zhang Z, Yang K. Low-frequency, high-impact: Discovering important rare events from UGC. Journal of Retailing and Consumer Services 2023;70:103153. [DOI: 10.1016/j.jretconser.2022.103153] [Reference Citation Analysis]
6 Liu J, Cheng Y, Li M, Zhang Z, Li T, Luo XJ. Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders. Neuropsychopharmacology 2023;48:270-80. [PMID: 36114287 DOI: 10.1038/s41386-022-01456-5] [Reference Citation Analysis]
7 Zazuli Z, Irham LM, Adikusuma W, Sari NM. Identification of Potential Treatments for Acute Lymphoblastic Leukemia through Integrated Genomic Network Analysis. Pharmaceuticals (Basel) 2022;15. [PMID: 36559013 DOI: 10.3390/ph15121562] [Reference Citation Analysis]
8 Yang C, Fagan AM, Perrin RJ, Rhinn H, Harari O, Cruchaga C. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes. Genome Med 2022;14:140. [PMID: 36510323 DOI: 10.1186/s13073-022-01140-9] [Reference Citation Analysis]
9 Afief AR, Irham LM, Adikusuma W, Perwitasari DA, Brahmadhi A, Cheung R. Integration of genomic variants and bioinformatic-based approach to drive drug repurposing for multiple sclerosis. Biochemistry and Biophysics Reports 2022;32:101337. [DOI: 10.1016/j.bbrep.2022.101337] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Namba S, Konuma T, Wu KH, Zhou W, Okada Y; Global Biobank Meta-analysis Initiative. A practical guideline of genomics-driven drug discovery in the era of global biobank meta-analysis. Cell Genom 2022;2:100190. [PMID: 36778001 DOI: 10.1016/j.xgen.2022.100190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Koch E, Demontis D. Drug repurposing candidates to treat core symptoms in autism spectrum disorder. Front Pharmacol 2022;13:995439. [DOI: 10.3389/fphar.2022.995439] [Reference Citation Analysis]
12 Bell N, Uffelmann E, van Walree E, de Leeuw C, Posthuma D. Using genome-wide association results to identify drug repurposing candidates.. [DOI: 10.1101/2022.09.06.22279660] [Reference Citation Analysis]
13 Reay WR, Geaghan MP, Atkins JR, Carr VJ, Green MJ, Cairns MJ. Genetics-informed precision treatment formulation in schizophrenia and bipolar disorder. Am J Hum Genet 2022;109:1620-37. [PMID: 36055211 DOI: 10.1016/j.ajhg.2022.07.011] [Reference Citation Analysis]
14 Sanchez-roige S, Kember RL, Agrawal A. Substance use and common contributors to morbidity: A genetics perspective. eBioMedicine 2022;83:104212. [DOI: 10.1016/j.ebiom.2022.104212] [Reference Citation Analysis]
15 Li Y, Sun Y, Liu Y, Wang B, Li J, Wang H, Zhang H, Wang X, Han X, Lin Q, Zhou Y, Hu L, Song Y, Bao J, Gong L, Sun M, Yuan X, Zhang X, Lian M, Xiao X, Miao Q, Wang Q, Li KK, Du S, Ma A, Li Y, Xu J, Tang S, Shi J, Xu Y, Yang L, Zhang J, Huang Z, Zhou L, Cui Y, Seldin MF, Gershwin ME, Yan H, Zou Z, Zuo X, Tang R, Ma X; Chinese AIH Consortium. Genome-wide meta-analysis identifies susceptibility loci for autoimmune hepatitis type 1. Hepatology 2022;76:564-75. [PMID: 35184318 DOI: 10.1002/hep.32417] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
16 Tsukumo SI, Subramani PG, Seija N, Tabata M, Maekawa Y, Mori Y, Ishifune C, Itoh Y, Ota M, Fujio K, Di Noia JM, Yasutomo K. AFF3, a susceptibility factor for autoimmune diseases, is a molecular facilitator of immunoglobulin class switch recombination. Sci Adv 2022;8:eabq0008. [PMID: 36001653 DOI: 10.1126/sciadv.abq0008] [Reference Citation Analysis]
17 Pinakhina D, Loboda A, Sergushichev A, Artomov M. GCDPipe: risk gene, cell type, and drug ranking for complex traits.. [DOI: 10.1101/2022.07.27.501775] [Reference Citation Analysis]
18 Reay WR, Geaghan MP, Cairns MJ; 23andMe Research Team. The genetic architecture of pneumonia susceptibility implicates mucin biology and a relationship with psychiatric illness. Nat Commun 2022;13:3756. [PMID: 35768473 DOI: 10.1038/s41467-022-31473-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Sun BB, Chiou J, Traylor M, Benner C, Hsu Y, Richardson TG, Surendran P, Mahajan A, Robins C, Vasquez-grinnell SG, Hou L, Kvikstad EM, Burren OS, Cule M, Davitte J, Ferber KL, Gillies CE, Hedman ÅK, Hu S, Lin T, Mikkilineni R, Pendergrass RK, Pickering C, Prins B, Raj A, Robinson J, Sethi A, Ward LD, Welsh S, Willis CM, Burkitt-gray L, Black MH, Fauman EB, Howson JMM, Kang HM, Mccarthy MI, Melamud E, Nioi P, Petrovski S, Scott RA, Smith EN, Szalma S, Waterworth DM, Mitnaul LJ, Szustakowski JD, Gibson BW, Miller MR, Whelan CD, Alnylam Human Genetics, AstraZeneca Genomics Initiative, Biogen Biobank Team, Bristol Myers Squibb, Genentech Human Genetics, GlaxoSmithKline Genomic Sciences, Pfizer Integrative Biology, Population Analytics of Janssen Data Sciences, Regeneron Genetics Center. Genetic regulation of the human plasma proteome in 54,306 UK Biobank participants.. [DOI: 10.1101/2022.06.17.496443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
20 International League Against Epilepsy Consortium on Complex Epilepsies, Berkovic SF, Cavalleri GL, Koeleman BP. Genome-wide meta-analysis of over 29,000 people with epilepsy reveals 26 loci and subtype-specific genetic architecture.. [DOI: 10.1101/2022.06.08.22276120] [Reference Citation Analysis]
21 Stolp Andersen M, Tan M, Holtman IR, Hardy J, Pihlstrøm L; International Parkinson's Disease Genomics Consortium. Dissecting the limited genetic overlap of Parkinson's and Alzheimer's disease. Ann Clin Transl Neurol 2022. [PMID: 35684951 DOI: 10.1002/acn3.51606] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Adams DM, Reay WR, Cairns MJ. Multiomic prioritisation of risk genes for anorexia nervosa.. [DOI: 10.1101/2022.06.04.22275898] [Reference Citation Analysis]
23 Zhang R, Oerlemans R, Wang C, Zhang L, R. Groves M. Drug Repurposing Techniques in Viral Diseases. Drug Repurposing - Molecular Aspects and Therapeutic Applications 2022. [DOI: 10.5772/intechopen.101443] [Reference Citation Analysis]
24 Lee C, Lin J, Prokop A, Gopalakrishnan V, Hanna RN, Papa E, Freeman A, Patel S, Yu W, Huhn M, Sheikh AS, Tan K, Sellman BR, Cohen T, Mangion J, Khan FM, Gusev Y, Shameer K. StarGazer: A Hybrid Intelligence Platform for Drug Target Prioritization and Digital Drug Repositioning Using Streamlit. Front Genet 2022;13:868015. [PMID: 35711912 DOI: 10.3389/fgene.2022.868015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Fang H. PiER: web-based facilities tailored for genetic target prioritisation harnessing human disease genetics, functional genomics and protein interactions. Nucleic Acids Res 2022:gkac379. [PMID: 35610036 DOI: 10.1093/nar/gkac379] [Reference Citation Analysis]
26 Attfield KE, Jensen LT, Kaufmann M, Friese MA, Fugger L. The immunology of multiple sclerosis. Nat Rev Immunol 2022. [PMID: 35508809 DOI: 10.1038/s41577-022-00718-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
27 Spence JP, Sinnott-armstrong N, Assimes TL, Pritchard JK. A flexible modeling and inference framework for estimating variant effect sizes from GWAS summary statistics.. [DOI: 10.1101/2022.04.18.488696] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
28 Reay WR, Kiltschewskij DJ, Geaghan MP, Atkins JR, Carr VJ, Green MJ, Cairns MJ. Genetic estimates of correlation and causality between blood-based biomarkers and psychiatric disorders. Sci Adv 2022;8:eabj8969. [PMID: 35385317 DOI: 10.1126/sciadv.abj8969] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
29 Jiang J, Hu C, Mcintosh AM, Shah S. Statins and antidepressants induce similar in vitro gene expression responses.. [DOI: 10.1101/2022.03.27.22273017] [Reference Citation Analysis]
30 Bao C, Wang H, Fang H. Genomic Evidence Supports the Recognition of Endometriosis as an Inflammatory Systemic Disease and Reveals Disease-Specific Therapeutic Potentials of Targeting Neutrophil Degranulation. Front Immunol 2022;13:758440. [DOI: 10.3389/fimmu.2022.758440] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Farrell SF, Kho P, Lundberg M, Campos AI, Rentería ME, de Zoete RMJ, Sterling M, Ngo TT, Cuéllar-partida G. A shared genetic signature for common chronic pain conditions and its impact on biopsychosocial traits.. [DOI: 10.1101/2022.03.13.22272317] [Reference Citation Analysis]
32 Fang J, Zhang P, Wang Q, Chiang CW, Zhou Y, Hou Y, Xu J, Chen R, Zhang B, Lewis SJ, Leverenz JB, Pieper AA, Li B, Li L, Cummings J, Cheng F. Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease. Alzheimers Res Ther 2022;14:7. [PMID: 35012639 DOI: 10.1186/s13195-021-00951-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
33 Mirza N, Stevelink R, Taweel B, Koeleman BPC, Marson AG; International League Against Epilepsy Consortium on Complex Epilepsies . Using common genetic variants to find drugs for common epilepsies. Brain Commun 2021;3:fcab287. [PMID: 34988442 DOI: 10.1093/braincomms/fcab287] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
34 Marini S, Georgakis MK, Anderson CD. Interactions Between Kidney Function and Cerebrovascular Disease: Vessel Pathology That Fires Together Wires Together. Front Neurol 2021;12:785273. [PMID: 34899586 DOI: 10.3389/fneur.2021.785273] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
35 Hu Y, Cheng X, Mao H, Chen X, Cui Y, Qiu Z. Causal Effects of Genetically Predicted Iron Status on Sepsis: A Two-Sample Bidirectional Mendelian Randomization Study. Front Nutr 2021;8:747547. [PMID: 34869523 DOI: 10.3389/fnut.2021.747547] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Namba S, Konuma T, Wu K, Zhou W, Okada Y, Global Biobank Meta-analysis Initiative. A practical guideline of genomics-driven drug discovery in the era of global biobank meta-analysis.. [DOI: 10.1101/2021.12.03.21267280] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
37 Li Q. New Etiological Insights of Psychiatric Disorders by Proteome-wide Association Study. Biol Psychiatry 2021;90:e61-2. [PMID: 34736557 DOI: 10.1016/j.biopsych.2021.09.015] [Reference Citation Analysis]
38 Zamami Y, Hamano H, Niimura T, Aizawa F, Yagi K, Goda M, Izawa-Ishizawa Y, Ishizawa K. Drug-Repositioning Approaches Based on Medical and Life Science Databases. Front Pharmacol 2021;12:752174. [PMID: 34790124 DOI: 10.3389/fphar.2021.752174] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
39 Fang H, Knight JC. Priority index: database of genetic targets in immune-mediated disease. Nucleic Acids Res 2021:gkab994. [PMID: 34751399 DOI: 10.1093/nar/gkab994] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
40 Okada Y, Wang QS. A massive effort links protein-coding gene variants to health. Nature 2021;599:561-3. [PMID: 34697483 DOI: 10.1038/d41586-021-02873-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Ramachandran D, Dörk T. Genomic Risk Factors for Cervical Cancer. Cancers (Basel) 2021;13:5137. [PMID: 34680286 DOI: 10.3390/cancers13205137] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]